Biological
V419 clinical trials
- studies test it
- 5
- open now
- 0
- in phase 3
- 5
- first study started
- 2011
How studies write it
Studies that test it under each name
Studies by the year they started
5 studies that test it; most in 2011 (4)
| Year | Studies |
|---|---|
| 2011 | 4 |
| 2013 | 1 |
By phase
A phase 1/2 study counts in both.
- Phase 3
- 5
What it is tested for
Each study’s main condition, where its own words name it.
Who runs them
Industry 5 · Other 0
MCM Vaccines B.V. (3) · Merck Sharp & Dohme LLC (2)
Often tested with
Tested in the same studies.
Diphtheria-tetanus-five component acellular pertussis-inactivated poliomyelitis -Haemophilus influenzae type b conjugate vaccine (1)
Studies
Open first, then newest update. How each study uses V419 is read from its arms, and is right about nine times in ten.
Testing it · 5
- Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 3, 4 and 12 Months (V419-007)CompletedPhase 3MCM Vaccines B.V.NCT01341639Written as V419
- Safety, Tolerability, and Immunogenicity of V419 in Healthy Infants When Given at 2, 4, and 11 to 12 Months (V419-008)CompletedPhase 3MCM Vaccines B.V.NCT01480258Written as PR5I
- Spanish Mixed HEXA/PENTA/HEXA Schedule (V419-010)CompletedPhase 3MCM Vaccines B.V.NCT01839188Written as PR5I
- Safety, Tolerability, and Immunogenicity of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-005)CompletedPhase 3Merck Sharp & Dohme LLCNCT01337167Written as V419
- A Study of V419 Given Concomitantly With Prevnar 13™ and RotaTeq™ (V419-006)CompletedPhase 3Merck Sharp & Dohme LLCNCT01340937Written as V419